News
Cowpea (Vigna unguiculata) is an indigenous and staple crop in sub-Saharan Africa, but it has an enemy: an insect called the ...
Biogen’s lack of insider buying and reduced R&D spending raise concerns, but its future growth prospects remain. Find out why BIIB stock is a hold.
Precision oncology company Guardant Health has announced a strategic collaboration with Pfizer to support the development and ...
Chinese biotech LTZ Therapeutics has closed an oversubscribed series A+ financing round, raising $40 million to support its ...
In the heart of Austin, where music and innovation often intersect, beloved local Casey McPherson’s story has struck a chord ...
India's fight against cervical cancer begins as it launches the first Made-in-India HPV (Human papillomavirus) test kit for ...
AACR conference chairs Lillian L. Siu, MD, and Matthew Vander Heiden, MD, PhD, share their perspectives on the event with GEN ...
Two hundred older adults in north Alabama could help rewrite the standard of care for people at risk of developing ...
Developments in genomics are enabling the rise of personalised medicine, with therapies tailored specifically for individuals ...
Kendall Square has become a hub of biotech innovation and a popular location for up and coming life sciences firms. Now, a ...
Union Minister for Science and Technology Dr Jitendra Singh inspected the various facilities at BRIC-inStem and underscored ...
A biotech firm based in Milton Park, Oxfordshire, has received a major boost after its T-cell therapy was awarded Breakthrough Therapy Designation by the US Food and Drug Administration, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results